The Christie Foundation Trust Annual Report and Accounts 2021-22

Directors’ Report

Executive Directors

He is a member of the National Cancer Board of NHS England and chairs their Early Detection and Screening Task and Finish Group. He is also a member of the Healthcare UK Panel of Advisors .

Roger Spencer Chief Executive Roger has been the Chief Executive since December 2013. He has managed significant Christie service developments including creation of a network of oncology (radiotherapy and chemotherapy) centres which have transformed delivery of services for the 3.2m population of Greater Manchester and Cheshire. He led the establishment of The Christie’s innovation partnerships with government, commercial, third sector and academic organisations. These include pathology, specialist diagnostic services, private patients (HCA Healthcare- The Christie Private Care) and an academic investment partnership. In 2016 he led the Trust to a CQC Outstanding rating, repeated in 2018. In the same year The Christie opened the UK’s first national proton service. Roger led for Greater Manchester on the National Cancer Vanguard developing and testing new models of care. He is the Chair of Greater Manchester Cancer Alliance (GM Cancer) and the Greater Manchester Clinical Research Network (GM CRN) and a member of the Manchester Cancer Research Centre Steering Board (MCRC Governance), working with a comprehensive group of stakeholders to improve and develop leading edge cancer services.

Professor Janelle Yorke Chief Nurse & Executive Director of Quality Professor Yorke was appointed as Executive Chief Nurse and Director of Quality in April 2020. She continues to hold the inaugural joint Chair in Cancer Nursing with the University of Manchester and The Christie, commencing May 2015. In 2016, she founded Christie Patient Centred Research (CPCR) and continues to lead this multi professional group of Christie researchers and students. During that time she also developed the bespoke Christie Clinical Academic Pathway (CCAP) supporting combined clinical and research pathways for cancer nurses and allied health professionals. She is Deputy Chair of Supportive and Palliative Care research at University of Manchester. She has secured research grants over £6M as a lead investigator and £20M as a co-investigator. Professor Yorke has particular expertise in the development and utilisation of Patient Reported Outcome - and Experience - Measures (PROMS/PREMS). She is internationally recognised as an expert in PROM work; her work includes symptom specific and quality of life measures that have been translated into more than 30 different languages. She chairs The Christie ePROM group, leading the

101